This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks in play: Microbix Biosystems Inc.

Baystreet.ca - Baystreet - Mon Apr 27, 9:06AM CDT

Announces that one of its clients is presenting results of Microbix made quality assessment products that help enable full-process quality management of molecular assays to detect human papillomavirus at 2026 PASCV. Microbix Biosystems Inc. shares T.MBX are trading up $0.01 at $0.25.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).